Functional and clinical significance of variants localized to 8q24 in colon cancer

Mine Cicek, Susan L Slager, Sara J. Achenbach, Amy J. French, Hilary E. Blair, Stephanie R. Fink, Nathan R. Foster, Brian F. Kabat, Kevin C. Halling, Julie M Cunningham, James R Cerhan, Robert Brian Jenkins, Lisa Allyn Boardman, Gloria M Petersen, Daniel J. Sargent, Steven Robert Alberts, Paul John Limburg, Stephen N Thibodeau

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Multiple genome-wide association studies have identified several susceptibility variants for colon cancer at 8q24. However, the functional roles of these variants have yet to be elucidated. Here, we evaluated the potential role of these markers in tumor progression and examined association with commonly observed structural abnormalities in this region, c-MYC amplification and chromosome fragility at FRA8C and FRA8D. We first replicated the previously reported association by testing 1,178 cases and 1,009 clinic-based controls with eight markers localized to three specific regions at 8q24. We observed significant associations with colon cancer risk with markers rs13254738 (ordinal odds ratio, 0.82; 95% confidence interval, 0.072-0.94; Ptrend = 0.0037) and rs6983267 (ordinal odds ratio, 1.17; 95% confidence interval, 1.03-1.32, Ptrend = 0.013). Survival analysis was done using a separate set of 460 cases to evaluate the clinical significance of these markers. Overall, univariate analysis did not detect survival differences for any of the markers. We also tested a subset of the 460 cases (n = 380) for structural abnormalities at or near the c-MYC locus using fluorescence in situ hybridization analysis. Furthermore, we evaluated a small number of cases homozygous for the rs6983267 alleles to test for differences in fragile site induction. None of the 8q markers correlated with amplification at the c-MYC locus as detected by fluorescence in situ hybridization, and no clear pattern of breakage was observed at the FRA8C and FRA8D sites. In this study, we confirm the association for several single nucleotide polymorphisms at 8q24 in colon cancer but have not detected any structural role relating to c-MYC amplification or chromosomal fragility. Finally, these risk alleles do not seem to be associated with survival.

Original languageEnglish (US)
Pages (from-to)2492-2500
Number of pages9
JournalCancer Epidemiology Biomarkers and Prevention
Volume18
Issue number9
DOIs
StatePublished - Sep 2009

Fingerprint

Chromosome Fragility
Colonic Neoplasms
Fluorescence In Situ Hybridization
Alleles
Odds Ratio
Confidence Intervals
Genome-Wide Association Study
Survival Analysis
Tumor Biomarkers
Single Nucleotide Polymorphism
Biomarkers

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Functional and clinical significance of variants localized to 8q24 in colon cancer. / Cicek, Mine; Slager, Susan L; Achenbach, Sara J.; French, Amy J.; Blair, Hilary E.; Fink, Stephanie R.; Foster, Nathan R.; Kabat, Brian F.; Halling, Kevin C.; Cunningham, Julie M; Cerhan, James R; Jenkins, Robert Brian; Boardman, Lisa Allyn; Petersen, Gloria M; Sargent, Daniel J.; Alberts, Steven Robert; Limburg, Paul John; Thibodeau, Stephen N.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 18, No. 9, 09.2009, p. 2492-2500.

Research output: Contribution to journalArticle

@article{d335375f66de4e9fa4bc1e55bae759d6,
title = "Functional and clinical significance of variants localized to 8q24 in colon cancer",
abstract = "Multiple genome-wide association studies have identified several susceptibility variants for colon cancer at 8q24. However, the functional roles of these variants have yet to be elucidated. Here, we evaluated the potential role of these markers in tumor progression and examined association with commonly observed structural abnormalities in this region, c-MYC amplification and chromosome fragility at FRA8C and FRA8D. We first replicated the previously reported association by testing 1,178 cases and 1,009 clinic-based controls with eight markers localized to three specific regions at 8q24. We observed significant associations with colon cancer risk with markers rs13254738 (ordinal odds ratio, 0.82; 95{\%} confidence interval, 0.072-0.94; Ptrend = 0.0037) and rs6983267 (ordinal odds ratio, 1.17; 95{\%} confidence interval, 1.03-1.32, Ptrend = 0.013). Survival analysis was done using a separate set of 460 cases to evaluate the clinical significance of these markers. Overall, univariate analysis did not detect survival differences for any of the markers. We also tested a subset of the 460 cases (n = 380) for structural abnormalities at or near the c-MYC locus using fluorescence in situ hybridization analysis. Furthermore, we evaluated a small number of cases homozygous for the rs6983267 alleles to test for differences in fragile site induction. None of the 8q markers correlated with amplification at the c-MYC locus as detected by fluorescence in situ hybridization, and no clear pattern of breakage was observed at the FRA8C and FRA8D sites. In this study, we confirm the association for several single nucleotide polymorphisms at 8q24 in colon cancer but have not detected any structural role relating to c-MYC amplification or chromosomal fragility. Finally, these risk alleles do not seem to be associated with survival.",
author = "Mine Cicek and Slager, {Susan L} and Achenbach, {Sara J.} and French, {Amy J.} and Blair, {Hilary E.} and Fink, {Stephanie R.} and Foster, {Nathan R.} and Kabat, {Brian F.} and Halling, {Kevin C.} and Cunningham, {Julie M} and Cerhan, {James R} and Jenkins, {Robert Brian} and Boardman, {Lisa Allyn} and Petersen, {Gloria M} and Sargent, {Daniel J.} and Alberts, {Steven Robert} and Limburg, {Paul John} and Thibodeau, {Stephen N}",
year = "2009",
month = "9",
doi = "10.1158/1055-9965.EPI-09-0362",
language = "English (US)",
volume = "18",
pages = "2492--2500",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Functional and clinical significance of variants localized to 8q24 in colon cancer

AU - Cicek, Mine

AU - Slager, Susan L

AU - Achenbach, Sara J.

AU - French, Amy J.

AU - Blair, Hilary E.

AU - Fink, Stephanie R.

AU - Foster, Nathan R.

AU - Kabat, Brian F.

AU - Halling, Kevin C.

AU - Cunningham, Julie M

AU - Cerhan, James R

AU - Jenkins, Robert Brian

AU - Boardman, Lisa Allyn

AU - Petersen, Gloria M

AU - Sargent, Daniel J.

AU - Alberts, Steven Robert

AU - Limburg, Paul John

AU - Thibodeau, Stephen N

PY - 2009/9

Y1 - 2009/9

N2 - Multiple genome-wide association studies have identified several susceptibility variants for colon cancer at 8q24. However, the functional roles of these variants have yet to be elucidated. Here, we evaluated the potential role of these markers in tumor progression and examined association with commonly observed structural abnormalities in this region, c-MYC amplification and chromosome fragility at FRA8C and FRA8D. We first replicated the previously reported association by testing 1,178 cases and 1,009 clinic-based controls with eight markers localized to three specific regions at 8q24. We observed significant associations with colon cancer risk with markers rs13254738 (ordinal odds ratio, 0.82; 95% confidence interval, 0.072-0.94; Ptrend = 0.0037) and rs6983267 (ordinal odds ratio, 1.17; 95% confidence interval, 1.03-1.32, Ptrend = 0.013). Survival analysis was done using a separate set of 460 cases to evaluate the clinical significance of these markers. Overall, univariate analysis did not detect survival differences for any of the markers. We also tested a subset of the 460 cases (n = 380) for structural abnormalities at or near the c-MYC locus using fluorescence in situ hybridization analysis. Furthermore, we evaluated a small number of cases homozygous for the rs6983267 alleles to test for differences in fragile site induction. None of the 8q markers correlated with amplification at the c-MYC locus as detected by fluorescence in situ hybridization, and no clear pattern of breakage was observed at the FRA8C and FRA8D sites. In this study, we confirm the association for several single nucleotide polymorphisms at 8q24 in colon cancer but have not detected any structural role relating to c-MYC amplification or chromosomal fragility. Finally, these risk alleles do not seem to be associated with survival.

AB - Multiple genome-wide association studies have identified several susceptibility variants for colon cancer at 8q24. However, the functional roles of these variants have yet to be elucidated. Here, we evaluated the potential role of these markers in tumor progression and examined association with commonly observed structural abnormalities in this region, c-MYC amplification and chromosome fragility at FRA8C and FRA8D. We first replicated the previously reported association by testing 1,178 cases and 1,009 clinic-based controls with eight markers localized to three specific regions at 8q24. We observed significant associations with colon cancer risk with markers rs13254738 (ordinal odds ratio, 0.82; 95% confidence interval, 0.072-0.94; Ptrend = 0.0037) and rs6983267 (ordinal odds ratio, 1.17; 95% confidence interval, 1.03-1.32, Ptrend = 0.013). Survival analysis was done using a separate set of 460 cases to evaluate the clinical significance of these markers. Overall, univariate analysis did not detect survival differences for any of the markers. We also tested a subset of the 460 cases (n = 380) for structural abnormalities at or near the c-MYC locus using fluorescence in situ hybridization analysis. Furthermore, we evaluated a small number of cases homozygous for the rs6983267 alleles to test for differences in fragile site induction. None of the 8q markers correlated with amplification at the c-MYC locus as detected by fluorescence in situ hybridization, and no clear pattern of breakage was observed at the FRA8C and FRA8D sites. In this study, we confirm the association for several single nucleotide polymorphisms at 8q24 in colon cancer but have not detected any structural role relating to c-MYC amplification or chromosomal fragility. Finally, these risk alleles do not seem to be associated with survival.

UR - http://www.scopus.com/inward/record.url?scp=70349313466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349313466&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-09-0362

DO - 10.1158/1055-9965.EPI-09-0362

M3 - Article

C2 - 19690179

AN - SCOPUS:70349313466

VL - 18

SP - 2492

EP - 2500

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -